Senolytic properties of DR5-selective TRAIL in pancreatic cancer cell lines
Acta Naturae · 23.07.2026 · 18 (2) · 76-84
DOI: 10.32607/actanaturae.27844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Naturae, online erschienen am 23.07.2026. Verfasst von A A Isakova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234 Russia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic adenocarcinoma is one of the most aggressive cancers. Its treatment relies on conventional chemotherapy agents; particularly gemcitabine. Chemotherapy is known to induce cell cycle arrest and the development of a senescent phenotype in tumor cells. The accumulation of senescent cells limits tumor proliferation, followed by the secretion of factors of the senescence-associated secretory phenotype promoting malignancy in the tumor microenvironment and metastasis. This makes the search for drugs suitable for senolytic therapy highly relevant. This study explored the senolytic properties of a DR5 receptor-selective mutant variant of the antitumor cytokine TRAIL DR5-B in human pancreatic cancer cell lines, after prolonged co-incubation with gemcitabine or doxorubicin. In the MIA PaCa-2 and PANC-1 cell lines, both drugs significantly increased β-galactosidase activity and the expression of senescence markers, such as the cell cycle inhibitors p21 and p27; DR5-B effectively suppressed cell viability after chemotherapy treatment. In the BxPC-3 cell line, the drugs did not induce senescence and DR5-B cytotoxicity was virtually unchanged. Some features of senescence were observed in AsPC-1 cells; however, these cells remained resistant to DR5-B, presumably due to cFLIP overexpression. Hence, the DR5-B protein shows promise as a senolytic agent for the treatment of certain types of pancreatic adenocarcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234 Russia.
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997 Russia.
- National Research University Higher School of Economics, Moscow, 101000 Russia.
Zitieren
APA
Isakova, A. A., Antipova, N. V., Mazur, D. V., Ivanova, E. I., Dolgikh, D. A., Kirpichnikov, M. P., Gasparian, M. E., & Yagolovich, A. V. (2026). Senolytic properties of DR5-selective TRAIL in pancreatic cancer cell lines. Acta Naturae, 18(2), 76-84. https://doi.org/10.32607/actanaturae.27844
Vancouver
Isakova AA, Antipova NV, Mazur DV, Ivanova EI, Dolgikh DA, Kirpichnikov MP, et al. Senolytic properties of DR5-selective TRAIL in pancreatic cancer cell lines. Acta Naturae. 2026;18(2):76-84. doi:10.32607/actanaturae.27844
BibTeX
@article{Isakova2026,
author = {Isakova, A A and Antipova, N V and Mazur, D V and Ivanova, E I and Dolgikh, D A and Kirpichnikov, M P and Gasparian, M E and Yagolovich, A V},
title = {Senolytic properties of DR5-selective TRAIL in pancreatic cancer cell lines},
journal = {Acta Naturae},
year = {2026},
volume = {18},
number = {2},
pages = {76--84},
doi = {10.32607/actanaturae.27844}
}
EUVIMED